BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36775264)

  • 1. [Expert consensus on the diagnosis and treatment of young breast cancer in China (2022 Edition)].
    ; ;
    Zhonghua Yi Xue Za Zhi; 2023 Feb; 103(6):387-403. PubMed ID: 36775264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expert consensus on endocrine therapy of breast cancer (2023 edition)].
    Zhang SH; Wang XJ; Jiang ZF
    Zhonghua Yi Xue Za Zhi; 2023 Oct; 103(38):2993-3001. PubMed ID: 37813650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Questions and reflections in the diagnosis and treatment of younger breast cancer in China].
    Jiang XT; Liu Q; Song EW
    Zhonghua Yi Xue Za Zhi; 2022 Sep; 102(36):2823-2827. PubMed ID: 36153866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chinese expert consensus of albumin-bound paclitaxel in the treatment of breast cancer].
    ;
    Zhonghua Zhong Liu Za Zhi; 2023 Mar; 45(3):203-211. PubMed ID: 36944541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chinese consensus guidelines for breast cancer in young women: clinical practice and fertility preservation].
    China Guideline Committee of Clinical Practice and Fertility Preservation for Breast Cancer in Young Women
    Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):486-495. PubMed ID: 31357834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expert consensus on fertility preservation in patients with breast cancer occurring during pregnancy.
    Ruan X;
    Gynecol Endocrinol; 2022 Oct; 38(10):797-802. PubMed ID: 36103898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Guidelines for clinical diagnosis and treatment of advanced triple negative breast cancer in China(2024 edition)].
    ; ;
    Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(0):471-480. PubMed ID: 38527739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Similarities and differences in diagnosis and treatment of gastrointestinal stromal tumors between China, Japan and Korea: from expert consensus to cooperation prospect].
    Cao H; Wang M
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):812-819. PubMed ID: 31550818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Guidelines for clinical diagnosis and treatment of advanced breast cancer in China (2020 Edition)].
    ; ;
    Zhonghua Zhong Liu Za Zhi; 2020 Oct; 42(10):781-797. PubMed ID: 33113619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Guidelines for clinical diagnosis and treatment of advanced breast cancer in China (2022 edition)].
    ; ;
    Zhonghua Zhong Liu Za Zhi; 2022 Dec; 44(12):1262-1287. PubMed ID: 36575780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expert consensus on the early diagnosis and treatment of colorectal cancer in China (2023 edition)].
    Expert Group on Early Diagnosis and Treatment of Cancer, Chinese Society of Oncology, Chinese Medical Association
    Zhonghua Yi Xue Za Zhi; 2023 Dec; 103(48):3896-3908. PubMed ID: 38129166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018).
    Xu B; Hu X; Feng J; Geng C; Jin F; Li H; Li M; Li Q; Liao N; Liu D; Liu J; Liu Q; Lu J; Liu Z; Ma F; Ouyang Q; Pan Y; Shen K; Sun T; Teng Y; Tong Z; Wang B; Wang H; Wang S; Wang S; Wang T; Wang X; Wang X; Wang Y; Wang Z; Wu J; Yan M; Yang J; Yin Y; Yuan P; Zhang J; Zhang P; Zhang Q; Zheng H
    Cancer; 2020 Aug; 126 Suppl 16():3867-3882. PubMed ID: 32710660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expert consensus on day care cancer diagnosis and treatment in China (2022 Edition)].
    China Tumor Day Diagnosis and Treatment Cooperative Group
    Zhonghua Zhong Liu Za Zhi; 2022 Apr; 44(4):307-320. PubMed ID: 35448918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Consensus of Chinese experts on hot issues in genetic testing of advanced breast cancer (2021 edition)].
    ;
    Zhonghua Zhong Liu Za Zhi; 2022 Jan; 44(1):60-67. PubMed ID: 35073649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chinese expert consensus on the clinical diagnosis and treatment of advanced breast carcinoma(2018)].
    Chinese Anti-Cancer Association, Committee of Breast Cancer Society
    Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):703-713. PubMed ID: 30293398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Guidelines for clinical application of platinum drugs in breast cancer (2023 edition)].
    Breast Cancer Group, Branch of Oncologist, Chinese Medical Doctor Association
    Zhonghua Zhong Liu Za Zhi; 2023 Dec; 45(12):1018-1031. PubMed ID: 38110310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Clinicopathological Features and Treatments between Young (≤40 Years) and Older (>40 Years) Female Breast Cancer Patients in West China: A Retrospective, Epidemiological, Multicenter, Case Only Study.
    Wang K; Ren Y; Li H; Zheng K; Jiang J; Zou T; Ma B; Li H; Liu Q; Ou J; Wang L; Wei W; He J; Ren G
    PLoS One; 2016; 11(3):e0152312. PubMed ID: 27031236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of AYA-generation breast cancer: trends worldwide and in Japan.
    Futamura M; Yoshida K
    Int J Clin Oncol; 2022 Jan; 27(1):16-24. PubMed ID: 34921319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Consensus on the clinical diagnosis, treatment, and prevention of cancer related anemia in China (2023 edition)].
    ;
    Zhonghua Zhong Liu Za Zhi; 2023 Dec; 45(12):1032-1040. PubMed ID: 38110311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.